Sandoz’s Erelzi receives FDA Approval making it the First US Enbrel Biosimilar
Sandoz, a Novartis company, has announced its drug, Erelzi, has been approved by the FDA, in a significant development. ...
PCI Services Expanding of Cryogenic Storage Facilities at our Rockford, IL Site
PCI Services are pleased to announce that we are extending our current Cryogenic storage capabilities to our Rockford , Illinois operations, complementing the specialized...
Egalet Announces OXAYDO Receives Pharmaceutical Composition Patent Protection Through 2024
Egalet Corporation a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions announced the issuance...
Spark Therapeutics and Pfizer receives FDA Designation for SPK-9001
Spark Therapeutics and Pfizer Inc announced that the U.S. FDA has granted breakthrough therapy designation to SPK-9001, the lead investigational candidate in the companies’...
Allergan Plc Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator
Allergan plc announced that it has filed with the U.S. FDA the de novo application for the Oculeve Intranasal Tear Neurostimulator device. ...
Advanced Clinical Receives Silver Award From Pro Unlimited Annual Global Supplier Awards
Advanced Clinical has been recognized as a Silver Award recipient of PRO Unlimited’s Annual Global Supplier Awards. Recipients of this award consistently deliver the...
Sandoz Biosimilar Etanercept Recommended By Fda For Approval To Treat Multiple Inflammatory Diseases
Sandoz, a Novartis division and leader in biosimilars, announced today that the US FDA Advisory Committee recommended approval of its proposed biosimilar etanercept.
The...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...